 | • レポートコード：GIR201114357 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、勃起不全の世界市場を調査対象にし、勃起不全の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ED用医薬品、EDデバイス）、用途別分析（先天性患者、病理患者）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Eli Lilly、Dong-A Socio、Boston Scientific、Pfizer、Cristalia Produtos Quimicos Farmaceuticos、Bayer、Futura Medical、Apricus Biosciences、Coloplast、Endo Pharmaceuticals、Vivus、Meda Pharmaceuticals、Zephyr Surgical Implants (ZSI)、Teva Pharmaceuticals、Promedon、SK Chemical ・企業別売上、市場シェア ・勃起不全の地域別市場分析 ・勃起不全の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・勃起不全のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・勃起不全のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・勃起不全の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・勃起不全の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・勃起不全の種類別市場規模2015-2020：ED用医薬品、EDデバイス ・勃起不全の用途別市場規模2015-2020：先天性患者、病理患者 ・勃起不全の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Erectile Dysfunction market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Erectile Dysfunction market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Erectile Dysfunction market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Erectile Dysfunction market has been segmented into:
ED Drugs
ED Devices
By Application, Erectile Dysfunction has been segmented into:
Congenital Patients
Pathological Patients
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Erectile Dysfunction market presented in the report. This section sheds light on the sales growth of different regional and country-level Erectile Dysfunction markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Erectile Dysfunction market.
The report offers in-depth assessment of the growth and other aspects of the Erectile Dysfunction market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Erectile Dysfunction Market Share Analysis
Erectile Dysfunction competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Erectile Dysfunction sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Erectile Dysfunction sales, revenue and market share for each player covered in this report.
The major players covered in Erectile Dysfunction are:
Eli Lilly
Dong-A Socio
Boston Scientific
Pfizer
Cristalia Produtos Quimicos Farmaceuticos
Bayer
Futura Medical
Apricus Biosciences
Coloplast
Endo Pharmaceuticals
Vivus
Meda Pharmaceuticals
Zephyr Surgical Implants (ZSI)
Teva Pharmaceuticals
Promedon
SK Chemical
Table of Contents
1 Erectile Dysfunction Market Overview
1.1 Product Overview and Scope of Erectile Dysfunction
1.2 Classification of Erectile Dysfunction by Type
1.2.1 Global Erectile Dysfunction Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Erectile Dysfunction Revenue Market Share by Type in 2019
1.2.3 ED Drugs
1.2.4 ED Devices
1.3 Global Erectile Dysfunction Market by Application
1.3.1 Overview: Global Erectile Dysfunction Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Congenital Patients
1.3.3 Pathological Patients
1.4 Global Erectile Dysfunction Market by Regions
1.4.1 Global Erectile Dysfunction Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Erectile Dysfunction (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Erectile Dysfunction Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Erectile Dysfunction Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Erectile Dysfunction Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Erectile Dysfunction Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Erectile Dysfunction Status and Prospect (2015-2025)
2 Company Profiles
2.1 Eli Lilly
2.1.1 Eli Lilly Details
2.1.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Eli Lilly SWOT Analysis
2.1.4 Eli Lilly Product and Services
2.1.5 Eli Lilly Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.2 Dong-A Socio
2.2.1 Dong-A Socio Details
2.2.2 Dong-A Socio Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Dong-A Socio SWOT Analysis
2.2.4 Dong-A Socio Product and Services
2.2.5 Dong-A Socio Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.3 Boston Scientific
2.3.1 Boston Scientific Details
2.3.2 Boston Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Boston Scientific SWOT Analysis
2.3.4 Boston Scientific Product and Services
2.3.5 Boston Scientific Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cristalia Produtos Quimicos Farmaceuticos
2.5.1 Cristalia Produtos Quimicos Farmaceuticos Details
2.5.2 Cristalia Produtos Quimicos Farmaceuticos Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cristalia Produtos Quimicos Farmaceuticos SWOT Analysis
2.5.4 Cristalia Produtos Quimicos Farmaceuticos Product and Services
2.5.5 Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bayer SWOT Analysis
2.6.4 Bayer Product and Services
2.6.5 Bayer Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.7 Futura Medical
2.7.1 Futura Medical Details
2.7.2 Futura Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Futura Medical SWOT Analysis
2.7.4 Futura Medical Product and Services
2.7.5 Futura Medical Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.8 Apricus Biosciences
2.8.1 Apricus Biosciences Details
2.8.2 Apricus Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Apricus Biosciences SWOT Analysis
2.8.4 Apricus Biosciences Product and Services
2.8.5 Apricus Biosciences Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.9 Coloplast
2.9.1 Coloplast Details
2.9.2 Coloplast Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Coloplast SWOT Analysis
2.9.4 Coloplast Product and Services
2.9.5 Coloplast Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.10 Endo Pharmaceuticals
2.10.1 Endo Pharmaceuticals Details
2.10.2 Endo Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Endo Pharmaceuticals SWOT Analysis
2.10.4 Endo Pharmaceuticals Product and Services
2.10.5 Endo Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.11 Vivus
2.11.1 Vivus Details
2.11.2 Vivus Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Vivus SWOT Analysis
2.11.4 Vivus Product and Services
2.11.5 Vivus Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.12 Meda Pharmaceuticals
2.12.1 Meda Pharmaceuticals Details
2.12.2 Meda Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Meda Pharmaceuticals SWOT Analysis
2.12.4 Meda Pharmaceuticals Product and Services
2.12.5 Meda Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.13 Zephyr Surgical Implants (ZSI)
2.13.1 Zephyr Surgical Implants (ZSI) Details
2.13.2 Zephyr Surgical Implants (ZSI) Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Zephyr Surgical Implants (ZSI) SWOT Analysis
2.13.4 Zephyr Surgical Implants (ZSI) Product and Services
2.13.5 Zephyr Surgical Implants (ZSI) Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.14 Teva Pharmaceuticals
2.14.1 Teva Pharmaceuticals Details
2.14.2 Teva Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Teva Pharmaceuticals SWOT Analysis
2.14.4 Teva Pharmaceuticals Product and Services
2.14.5 Teva Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.15 Promedon
2.15.1 Promedon Details
2.15.2 Promedon Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Promedon SWOT Analysis
2.15.4 Promedon Product and Services
2.15.5 Promedon Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
2.16 SK Chemical
2.16.1 SK Chemical Details
2.16.2 SK Chemical Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 SK Chemical SWOT Analysis
2.16.4 SK Chemical Product and Services
2.16.5 SK Chemical Erectile Dysfunction Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Erectile Dysfunction Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Erectile Dysfunction Players Market Share
3.2.2 Top 10 Erectile Dysfunction Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Erectile Dysfunction Revenue and Market Share by Regions
4.2 North America Erectile Dysfunction Revenue and Growth Rate (2015-2020)
4.3 Europe Erectile Dysfunction Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Erectile Dysfunction Revenue and Growth Rate (2015-2020)
4.5 South America Erectile Dysfunction Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Erectile Dysfunction Revenue and Growth Rate (2015-2020)
5 North America Erectile Dysfunction Revenue by Countries
5.1 North America Erectile Dysfunction Revenue by Countries (2015-2020)
5.2 USA Erectile Dysfunction Revenue and Growth Rate (2015-2020)
5.3 Canada Erectile Dysfunction Revenue and Growth Rate (2015-2020)
5.4 Mexico Erectile Dysfunction Revenue and Growth Rate (2015-2020)
6 Europe Erectile Dysfunction Revenue by Countries
6.1 Europe Erectile Dysfunction Revenue by Countries (2015-2020)
6.2 Germany Erectile Dysfunction Revenue and Growth Rate (2015-2020)
6.3 UK Erectile Dysfunction Revenue and Growth Rate (2015-2020)
6.4 France Erectile Dysfunction Revenue and Growth Rate (2015-2020)
6.5 Russia Erectile Dysfunction Revenue and Growth Rate (2015-2020)
6.6 Italy Erectile Dysfunction Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Erectile Dysfunction Revenue by Countries
7.1 Asia-Pacific Erectile Dysfunction Revenue by Countries (2015-2020)
7.2 China Erectile Dysfunction Revenue and Growth Rate (2015-2020)
7.3 Japan Erectile Dysfunction Revenue and Growth Rate (2015-2020)
7.4 Korea Erectile Dysfunction Revenue and Growth Rate (2015-2020)
7.5 India Erectile Dysfunction Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Erectile Dysfunction Revenue and Growth Rate (2015-2020)
8 South America Erectile Dysfunction Revenue by Countries
8.1 South America Erectile Dysfunction Revenue by Countries (2015-2020)
8.2 Brazil Erectile Dysfunction Revenue and Growth Rate (2015-2020)
8.3 Argentina Erectile Dysfunction Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Erectile Dysfunction by Countries
9.1 Middle East & Africa Erectile Dysfunction Revenue by Countries (2015-2020)
9.2 Saudi Arabia Erectile Dysfunction Revenue and Growth Rate (2015-2020)
9.3 UAE Erectile Dysfunction Revenue and Growth Rate (2015-2020)
9.4 Egypt Erectile Dysfunction Revenue and Growth Rate (2015-2020)
9.5 South Africa Erectile Dysfunction Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Erectile Dysfunction Revenue and Market Share by Type (2015-2020)
10.2 Global Erectile Dysfunction Market Forecast by Type (2019-2024)
10.3 ED Drugs Revenue Growth Rate (2015-2025)
10.4 ED Devices Revenue Growth Rate (2015-2025)
11 Global Erectile Dysfunction Market Segment by Application
11.1 Global Erectile Dysfunction Revenue Market Share by Application (2015-2020)
11.2 Erectile Dysfunction Market Forecast by Application (2019-2024)
11.3 Congenital Patients Revenue Growth (2015-2020)
11.4 Pathological Patients Revenue Growth (2015-2020)
12 Global Erectile Dysfunction Market Size Forecast (2021-2025)
12.1 Global Erectile Dysfunction Market Size Forecast (2021-2025)
12.2 Global Erectile Dysfunction Market Forecast by Regions (2021-2025)
12.3 North America Erectile Dysfunction Revenue Market Forecast (2021-2025)
12.4 Europe Erectile Dysfunction Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Erectile Dysfunction Revenue Market Forecast (2021-2025)
12.6 South America Erectile Dysfunction Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Erectile Dysfunction Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Erectile Dysfunction Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Erectile Dysfunction by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Erectile Dysfunction Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Erectile Dysfunction Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Eli Lilly Corporate Information, Location and Competitors
Table 6. Eli Lilly Erectile Dysfunction Major Business
Table 7. Eli Lilly Erectile Dysfunction Total Revenue (USD Million) (2017-2018)
Table 8. Eli Lilly SWOT Analysis
Table 9. Eli Lilly Erectile Dysfunction Product and Solutions
Table 10. Eli Lilly Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Dong-A Socio Corporate Information, Location and Competitors
Table 12. Dong-A Socio Erectile Dysfunction Major Business
Table 13. Dong-A Socio Erectile Dysfunction Total Revenue (USD Million) (2018-2019)
Table 14. Dong-A Socio SWOT Analysis
Table 15. Dong-A Socio Erectile Dysfunction Product and Solutions
Table 16. Dong-A Socio Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Boston Scientific Corporate Information, Location and Competitors
Table 18. Boston Scientific Erectile Dysfunction Major Business
Table 19. Boston Scientific Erectile Dysfunction Total Revenue (USD Million) (2017-2018)
Table 20. Boston Scientific SWOT Analysis
Table 21. Boston Scientific Erectile Dysfunction Product and Solutions
Table 22. Boston Scientific Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Pfizer Corporate Information, Location and Competitors
Table 24. Pfizer Erectile Dysfunction Major Business
Table 25. Pfizer Erectile Dysfunction Total Revenue (USD Million) (2017-2018)
Table 26. Pfizer SWOT Analysis
Table 27. Pfizer Erectile Dysfunction Product and Solutions
Table 28. Pfizer Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Cristalia Produtos Quimicos Farmaceuticos Corporate Information, Location and Competitors
Table 30. Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Major Business
Table 31. Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Total Revenue (USD Million) (2017-2018)
Table 32. Cristalia Produtos Quimicos Farmaceuticos SWOT Analysis
Table 33. Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Product and Solutions
Table 34. Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bayer Corporate Information, Location and Competitors
Table 36. Bayer Erectile Dysfunction Major Business
Table 37. Bayer Erectile Dysfunction Total Revenue (USD Million) (2017-2018)
Table 38. Bayer SWOT Analysis
Table 39. Bayer Erectile Dysfunction Product and Solutions
Table 40. Bayer Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Futura Medical Corporate Information, Location and Competitors
Table 42. Futura Medical Erectile Dysfunction Major Business
Table 43. Futura Medical Erectile Dysfunction Total Revenue (USD Million) (2017-2018)
Table 44. Futura Medical SWOT Analysis
Table 45. Futura Medical Erectile Dysfunction Product and Solutions
Table 46. Futura Medical Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Apricus Biosciences Corporate Information, Location and Competitors
Table 48. Apricus Biosciences Erectile Dysfunction Major Business
Table 49. Apricus Biosciences Erectile Dysfunction Total Revenue (USD Million) (2017-2018)
Table 50. Apricus Biosciences SWOT Analysis
Table 51. Apricus Biosciences Erectile Dysfunction Product and Solutions
Table 52. Apricus Biosciences Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Coloplast Corporate Information, Location and Competitors
Table 54. Coloplast Erectile Dysfunction Major Business
Table 55. Coloplast Erectile Dysfunction Total Revenue (USD Million) (2017-2018)
Table 56. Coloplast SWOT Analysis
Table 57. Coloplast Erectile Dysfunction Product and Solutions
Table 58. Coloplast Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Endo Pharmaceuticals Corporate Information, Location and Competitors
Table 60. Endo Pharmaceuticals Erectile Dysfunction Major Business
Table 61. Endo Pharmaceuticals Erectile Dysfunction Total Revenue (USD Million) (2017-2018)
Table 62. Endo Pharmaceuticals SWOT Analysis
Table 63. Endo Pharmaceuticals Erectile Dysfunction Product and Solutions
Table 64. Endo Pharmaceuticals Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Vivus Corporate Information, Location and Competitors
Table 66. Vivus Erectile Dysfunction Major Business
Table 67. Vivus Erectile Dysfunction Total Revenue (USD Million) (2017-2018)
Table 68. Vivus SWOT Analysis
Table 69. Vivus Erectile Dysfunction Product and Solutions
Table 70. Vivus Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Meda Pharmaceuticals Corporate Information, Location and Competitors
Table 72. Meda Pharmaceuticals Erectile Dysfunction Major Business
Table 73. Meda Pharmaceuticals Erectile Dysfunction Total Revenue (USD Million) (2017-2018)
Table 74. Meda Pharmaceuticals SWOT Analysis
Table 75. Meda Pharmaceuticals Erectile Dysfunction Product and Solutions
Table 76. Meda Pharmaceuticals Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Zephyr Surgical Implants (ZSI) Corporate Information, Location and Competitors
Table 78. Zephyr Surgical Implants (ZSI) Erectile Dysfunction Major Business
Table 79. Zephyr Surgical Implants (ZSI) Erectile Dysfunction Total Revenue (USD Million) (2017-2018)
Table 80. Zephyr Surgical Implants (ZSI) SWOT Analysis
Table 81. Zephyr Surgical Implants (ZSI) Erectile Dysfunction Product and Solutions
Table 82. Zephyr Surgical Implants (ZSI) Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Teva Pharmaceuticals Corporate Information, Location and Competitors
Table 84. Teva Pharmaceuticals Erectile Dysfunction Major Business
Table 85. Teva Pharmaceuticals Erectile Dysfunction Total Revenue (USD Million) (2017-2018)
Table 86. Teva Pharmaceuticals SWOT Analysis
Table 87. Teva Pharmaceuticals Erectile Dysfunction Product and Solutions
Table 88. Teva Pharmaceuticals Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Promedon Corporate Information, Location and Competitors
Table 90. Promedon Erectile Dysfunction Major Business
Table 91. Promedon Erectile Dysfunction Total Revenue (USD Million) (2017-2018)
Table 92. Promedon SWOT Analysis
Table 93. Promedon Erectile Dysfunction Product and Solutions
Table 94. Promedon Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. SK Chemical Corporate Information, Location and Competitors
Table 96. SK Chemical Erectile Dysfunction Major Business
Table 97. SK Chemical Erectile Dysfunction Total Revenue (USD Million) (2017-2018)
Table 98. SK Chemical SWOT Analysis
Table 99. SK Chemical Erectile Dysfunction Product and Solutions
Table 100. SK Chemical Erectile Dysfunction Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Global Erectile Dysfunction Revenue (Million USD) by Players (2015-2020)
Table 102. Global Erectile Dysfunction Revenue Share by Players (2015-2020)
Table 103. Global Erectile Dysfunction Revenue (Million USD) by Regions (2015-2020)
Table 104. Global Erectile Dysfunction Revenue Market Share by Regions (2015-2020)
Table 105. North America Erectile Dysfunction Revenue by Countries (2015-2020)
Table 106. North America Erectile Dysfunction Revenue Market Share by Countries (2015-2020)
Table 107. Europe Erectile Dysfunction Revenue (Million USD) by Countries (2015-2020)
Table 108. Asia-Pacific Erectile Dysfunction Revenue (Million USD) by Countries (2015-2020)
Table 109. South America Erectile Dysfunction Revenue by Countries (2015-2020)
Table 110. South America Erectile Dysfunction Revenue Market Share by Countries (2015-2020)
Table 111. Middle East and Africa Erectile Dysfunction Revenue (Million USD) by Countries (2015-2020)
Table 112. Middle East and Africa Erectile Dysfunction Revenue Market Share by Countries (2015-2020)
Table 113. Global Erectile Dysfunction Revenue (Million USD) by Type (2015-2020)
Table 114. Global Erectile Dysfunction Revenue Share by Type (2015-2020)
Table 115. Global Erectile Dysfunction Revenue Forecast by Type (2021-2025)
Table 116. Global Erectile Dysfunction Revenue by Application (2015-2020)
Table 117. Global Erectile Dysfunction Revenue Share by Application (2015-2020)
Table 118. Global Erectile Dysfunction Revenue Forecast by Application (2021-2025)
Table 119. Global Erectile Dysfunction Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Erectile Dysfunction Picture
Figure 2. Global Erectile Dysfunction Revenue Market Share by Type in 2019
Figure 3. ED Drugs Picture
Figure 4. ED Devices Picture
Figure 5. Erectile Dysfunction Revenue Market Share by Application in 2019
Figure 6. Congenital Patients Picture
Figure 7. Pathological Patients Picture
Figure 8. Global Erectile Dysfunction Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Erectile Dysfunction Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Erectile Dysfunction Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Erectile Dysfunction Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Erectile Dysfunction Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Erectile Dysfunction Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Erectile Dysfunction Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Erectile Dysfunction Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Erectile Dysfunction Revenue Market Share in 2019
Figure 17. Global Top 10 Players Erectile Dysfunction Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Erectile Dysfunction Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Erectile Dysfunction Revenue Market Share by Regions (2015-2020)
Figure 21. Global Erectile Dysfunction Revenue Market Share by Regions in 2018
Figure 22. North America Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 23. Europe Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 25. South America Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 27. North America Erectile Dysfunction Revenue Market Share by Countries (2015-2020)
Figure 28. North America Erectile Dysfunction Revenue Market Share by Countries in 2019
Figure 29. USA Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 30. Canada Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 32. Europe Erectile Dysfunction Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Erectile Dysfunction Revenue Market Share by Countries in 2019
Figure 34. Germany Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 35. UK Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 36. France Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 37. Russia Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 38. Italy Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Erectile Dysfunction Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Erectile Dysfunction Revenue Market Share by Countries in 2019
Figure 41. China Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 42. Japan Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 43. Korea Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 44. India Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 46. South America Erectile Dysfunction Revenue Market Share by Countries (2015-2020)
Figure 47. South America Erectile Dysfunction Revenue Market Share by Countries in 2019
Figure 48. Brazil Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Erectile Dysfunction Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Erectile Dysfunction Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 53. UAE Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Erectile Dysfunction Revenue and Growth Rate (2015-2020)
Figure 56. Global Erectile Dysfunction Revenue Share by Type (2015-2020)
Figure 57. Global Erectile Dysfunction Revenue Share by Type in 2019
Figure 58. Global Erectile Dysfunction Market Share Forecast by Type (2021-2025)
Figure 59. Global ED Drugs Revenue Growth Rate (2015-2020)
Figure 60. Global ED Devices Revenue Growth Rate (2015-2020)
Figure 61. Global Erectile Dysfunction Revenue Share by Application (2015-2020)
Figure 62. Global Erectile Dysfunction Revenue Share by Application in 2019
Figure 63. Global Erectile Dysfunction Market Share Forecast by Application (2021-2025)
Figure 64. Global Congenital Patients Revenue Growth Rate (2015-2020)
Figure 65. Global Pathological Patients Revenue Growth Rate (2015-2020)
Figure 66. Global Erectile Dysfunction Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Erectile Dysfunction Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Erectile Dysfunction Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Erectile Dysfunction Revenue Market Forecast (2021-2025)
Figure 70. Europe Erectile Dysfunction Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Erectile Dysfunction Revenue Market Forecast (2021-2025)
Figure 72. South America Erectile Dysfunction Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Erectile Dysfunction Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
勃起不全デバイスの世界市場 2020年 Market Overview The global Erectile Dysfunction Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.1% in the forecast period of 2020 to 2025 and will expected to reach USD 1641.3 million by 2025, from USD 1345.2 million in 2019. The Erectil…- 電気治療システムの世界市場 2020年 Market Overview The global Electrotherapy System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Electrotherapy System m…
- 糖尿病ケア機器・薬物の世界市場 2020年 Market Overview The global Diabetes Care Devices & Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diabetes Care D…
- エクセナチド薬の世界市場 2020年 Market Overview The global Exenatide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Exenatide Drugs market report…
- テデュグルチド薬の世界市場 2020年 Market Overview The global Teduglutide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Teduglutide Drugs market re…